Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 487-490

  Schmit, Isabelle ^a   Boivin, Guy ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; THYMIDINE KINASE; VIRUS ENZYME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FRAMESHIFT MUTATION; GENOTYPE; HERPES SIMPLEX VIRUS; HUMAN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS ISOLATION;

ACYCLOVIR; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; FOSCARNET; GENE PRODUCTS, POL; HERPES SIMPLEX; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; SIMPLEXVIRUS; THYMIDINE KINASE; TREATMENT FAILURE;

EID: 0033495719     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314900     Document Type: Article

References (15)

1. 1. Balfour HHJ. Resistance of herpes simplex to acyclovir. Ann Intern Med 1983; 98:404-6.
2. 2. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991; 325:551-5.
3. 3. Gaudreau A, Hill E, Balfour HHJ, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998; 178:297-303.
4. 4. Sasadeusz JJ, Tufaro F, Safrin S, et al. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol 1997; 71: 3872-8.
5. 5. Larder BA, Kemp SD, Darby G. Related functional domains in virus DNA polymerases. EMBO J 1987,6:169-75.
6. 6. Matthews JT, Terry BJ, Field AK. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets. Antiviral Res 1993; 20:89-114.
7. 7. Hall JD, Wang YS, Pierpont J, Berlin MS, Rundlett SE, Woodward S. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site. Nucleic Acids Res 1989; 17:9231-44.
8. 8. Gibbs JS, Chiou HC, Bastow KK, Cheng YC, Coen DM. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci USA 1988; 85:6672-6.
9. 9. Dorsky DI, Plourde C. Resistance to antiviral inhibitors caused by the mutation S889A in the highly-conserved 885-GDTDS motif of the herpes simplex virus type 1 DNA polymerase. Virology 1993; 195:831-5.
10. 10. Collins P, Larder BA, Oliver NM, Kemp S, Smith IW, Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol 1989; 70:375-82.
11. 11. Hwang CB, Ruffner KL, Coen DM. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J Virol 1992; 66:1774-6.
12. 12. Safrin S, Kemmerly S, Plotkin B, et al. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 1994; 169:193-6.
13. 13 Baldanti F, Underwood MR, Stanat SC, et al. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 1996; 70:1390-5.
14. 14. Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis 1997; 176:69-77.
15. 15. Chou S, Marousek G, Parenti DM, et al. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis 1998; 178:526-30.